HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Europe Continues Clampdown On Unauthorized CBD Supplements

Executive Summary

Numerous European countries are continuing to crack down on the sale of unauthorized CBD food products on safety grounds, an analysis by HBW Insight reveals. Germany and Denmark are leading the way in submitting reports to Europe's Rapid Alert System for Food and Feed.

You may also be interested in...



Belgium Leading The Charge Against Unauthorized CBD Supplements Sold In EU

With no CBD product yet approved under Europe’s novel foods regulation, Belgium is cracking down on unauthorized supplements and alerting its neighbors, an analysis by HBW Insight reveals. 

German CBD Regulation ‘Moving Slowly In The Right Direction’

A recent court case and an upcoming federal election promise movement in Germany's cannbidiol market, stated Joscha Krauss, CEO of local manufacturer MH Medical Hemp GmbH, at the 18th European Industrial Hemp Association (EIHA) Annual Conference.

People On The Move: Appointments At CRN UK, EMA, Boots

A round-up of the latest European executive appointments: CRN UK hires scientific advisor; EMA management board names vice chair; Boots UK appoints chief digital officer.

Topics

Latest News
UsernamePublicRestriction

Register

RS152217

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel